Janssen-Cilag International NV has announced results from the phase 3 MARIPOSA study, demonstrating a significant overall ...

Scientists from Juntendo University and The University of Tokyo have created an adeno-associated virus (AAV)-based genome ...

Nouscom has announced full safety and immunogenicity results from its phase 1b/2 trial of NOUS-209, an off-the-shelf ...

Sygnature Discovery has announced the appointment of Kieron Hall as its new Chief Commercial Officer (CCO) and Board member.

Abrysvo, which is now the first maternal RSV vaccine to be prequalified by the organisation, aims to prevent RSV-associated ...

The Drug Safety Research Unit has announced Linda Härmark as its new Director. She succeeds Professor Saad Shakir who officially steps down from the position after 26 years. Linda joins the DSRU, ...

Orca Bio has shared promising results from a late-stage study of its investigational allogeneic T-cell immunotherapy in ...

Careology and Entia have announced a partnership to enhance cancer care through innovative digital and at-home solutions. The ...

Anocca has achieved regulatory approval for its first clinical trial, VIDAR-1, a major milestone in the company’s transition ...

Nuclera, the biotechnology company accelerating protein expression and optimisation through its benchtop eProtein Discovery system, has announced that it has appointed Seth Benson as Chief Financial ...

Aragen has announced the appointment of Manjunath Ramarao as Chief Scientific Officer (CSO) and Executive Vice President of ...

Sygnature Discovery has announced the appointment of Kieron Hall as its new Chief Commercial Officer (CCO) and Board member. Kieron will play a key role in driving Sygnature Discovery’s strategic ...